Nature Communications,
Journal Year:
2020,
Volume and Issue:
11(1)
Published: June 23, 2020
Abstract
SAMHD1
regulates
cellular
2′-deoxynucleoside-5′-triphosphate
(dNTP)
homeostasis
by
catalysing
the
hydrolysis
of
dNTPs
into
2′-deoxynucleosides
and
triphosphate.
In
CD4
+
myeloid
lineage
resting
T-cells,
blocks
HIV-1
other
viral
infections
depletion
dNTP
pool
to
a
level
that
cannot
support
replication.
mutations
are
associated
with
autoimmune
disease
Aicardi–Goutières
syndrome
hypermutated
cancers.
Furthermore,
sensitises
cancer
cells
nucleoside-analogue
anti-cancer
therapies
is
linked
DNA
repair
suppression
interferon
response
cytosolic
nucleic
acids.
Nevertheless,
despite
its
requirement
in
these
processes,
fundamental
mechanism
SAMHD1-catalysed
remained
unknown.
Here,
we
present
structural
enzymological
data
showing
utilises
an
active
site,
bi-metallic
iron-magnesium
centre
positions
hydroxide
nucleophile
in-line
P
α
-O
5′
bond
catalyse
phosphoester
hydrolysis.
This
precise
molecular
for
catalysis,
reveals
how
down-regulates
modulates
efficacy
nucleoside-based
anti-viral
therapies.
Nature Communications,
Journal Year:
2018,
Volume and Issue:
9(1)
Published: June 4, 2018
Abstract
SAMHD1
is
a
critical
restriction
factor
for
HIV-1
in
non-cycling
cells
and
its
antiviral
activity
regulated
by
T592
phosphorylation.
Here,
we
show
that
dephosphorylation
at
controlled
during
the
cell
cycle,
occurring
M/G
1
transition
proliferating
cells.
Using
several
complementary
proteomics
biochemical
approaches,
identify
phosphatase
PP2A-B55α
responsible
rendering
antivirally
active.
specifically
targeted
holoenzymes
mitotic
exit,
line
with
observations
key
exit
mammalian
Strikingly,
as
HeLa
or
activated
primary
CD4
+
T
enter
G
phase,
pronounced
reduction
of
RT
products
observed
upon
infection
dependent
on
presence
dephosphorylated
SAMHD1.
Moreover,
PP2A
controls
pT592
level
monocyte-derived
macrophages
(MDMs).
Thus,
holoenzyme
regulator
to
switch
Scientific Reports,
Journal Year:
2016,
Volume and Issue:
6(1)
Published: Aug. 11, 2016
Abstract
SAMHD1,
a
dNTP
triphosphohydrolase,
contributes
to
interferon
signaling
and
restriction
of
retroviral
replication.
SAMHD1-mediated
is
thought
result
from
the
depletion
cellular
pools,
but
it
remains
controversial
whether
dNTPase
activity
SAMHD1
sufficient
for
restriction.
The
ability
regulated
in
cells
by
phosphorylation
on
T592.
Phosphomimetic
mutations
T592
are
not
competent,
appear
intact
their
deplete
dNTPs.
Here
we
use
analytical
ultracentrifugation,
fluorescence
polarization
NMR-based
enzymatic
assays
investigate
impact
phosphomimetic
tetramerization
vitro
.
We
find
that
affect
kinetics
tetramer
assembly
disassembly,
effects
equilibrium
insignificant.
In
contrast,
Y146S/Y154S
dimerization-defective
mutant
displays
severe
defect
,
indistinguishable
WT
its
pools
restrict
HIV
Our
data
suggest
effect
likely
explain
hypothesize
subject
additional
regulatory
mechanisms
have
yet
been
recapitulated
Retrovirology,
Journal Year:
2015,
Volume and Issue:
12(1)
Published: Dec. 1, 2015
Human
SAMHD1
is
a
triphosphohydrolase
that
restricts
the
replication
of
retroviruses,
retroelements
and
DNA
viruses
in
noncycling
cells.
While
modes
action
have
been
extensively
described
for
human
SAMHD1,
only
little
known
about
regulation
mouse.
Here,
we
characterize
antiviral
activity
murine
with
help
knockout
mice
to
shed
light
on
mechanism
restriction
validate
mouse
model
use
future
infectivity
studies.We
found
endogenous
not
HIV-1
but
also
MLV
reporter
virus
infection
at
level
reverse
transcription
primary
myeloid
Similar
protein,
regulated
through
phosphorylation
threonine
603
limited
nondividing
Comparing
susceptibility
intracellular
dNTP
levels
different
cell
types
shows
both
functions
are
important
determinants
SAMHD1.
In
contrast,
proposed
RNase
be
less
could
detect
any
effect
or
incoming
viral
RNA.Our
findings
show
blocks
retroviral
cycle-dependent
phosphorylation.
We
mediated
by
mechanistically
similar
what
making
valuable
tool
influence
vivo.
Proceedings of the National Academy of Sciences,
Journal Year:
2019,
Volume and Issue:
116(43), P. 21685 - 21693
Published: Oct. 7, 2019
The
human
dendritic
cell
(DC)
lineage
has
recently
been
unraveled
by
high-dimensional
mapping,
revealing
the
existence
of
a
discrete
new
population
blood
circulating
DC
precursors
(pre-DCs).
Whether
this
possesses
specific
functional
features
as
compared
to
other
subset
upon
pathogen
encounter
remained
be
evaluated.
A
unique
feature
pre-DCs
among
DCs
is
their
constitutive
expression
viral
adhesion
receptor
Siglec-1.
Here,
we
show
that
pre-DCs,
but
not
subsets,
are
susceptible
infection
HIV-1
in
Siglec-1–dependent
manner.
Siglec-1
mediates
pre-DC
CCR5-
and
CXCR4-tropic
strains.
Infection
further
enhanced
presence
HIV-2/SIVmac
Vpx,
indicating
does
counteract
restriction
factors
such
SAMHD1.
Instead,
promotes
attachment
fusion
particles.
HIV-1–infected
produce
infectious
particles
accumulate
intracellular
compartments
reminiscent
virus-containing
compartment
macrophages.
Pre-DC
activation
toll-like
(TLR)
ligands
induces
an
antiviral
state
inhibits
infection,
remains
replication-independent
transfer
activated
primary
T
lymphocytes.
Altogether,
Siglec-1–mediated
susceptibility
constitutes
might
represent
preferential
relationship
emerging
type
with
viruses.
EMBO Molecular Medicine,
Journal Year:
2020,
Volume and Issue:
12(3)
Published: Jan. 17, 2020
The
deoxycytidine
analogue
cytarabine
(ara-C)
remains
the
backbone
treatment
of
acute
myeloid
leukaemia
(AML)
as
well
other
haematological
and
lymphoid
malignancies,
but
must
be
combined
with
chemotherapeutics
to
achieve
cure.
Yet,
underlying
mechanism
dictating
synergistic
efficacy
combination
chemotherapy
largely
unknown.
dNTPase
SAMHD1,
which
regulates
dNTP
homoeostasis
antagonistically
ribonucleotide
reductase
(RNR),
limits
ara-C
by
hydrolysing
active
triphosphate
metabolite
ara-CTP.
Here,
we
report
that
clinically
used
inhibitors
RNR,
such
gemcitabine
hydroxyurea,
overcome
SAMHD1-mediated
barrier
in
primary
blasts
mouse
models
AML,
displaying
SAMHD1-dependent
synergy
ara-C.
We
present
evidence
this
is
mediated
pool
imbalances
leading
allosteric
reduction
SAMHD1
ara-CTPase
activity.
Thus,
constitutes
a
novel
biomarker
for
therapies
RNR
immediate
consequences
clinical
practice
improve
AML.
Autoimmunity,
Journal Year:
2018,
Volume and Issue:
51(3), P. 96 - 110
Published: March 27, 2018
Sterile
alpha
motif
and
histidine-aspartic
acid
domain-containing
protein
1
(SAMHD1)
is
a
deoxynucleotide
triphosphate
(dNTP)
hydrolase
that
plays
an
important
role
in
the
homeostatic
balance
of
cellular
dNTPs.
Its
emerging
as
effector
innate
immunity
affirmed
by
mutations
SAMHD1
gene
cause
severe
autoimmune
disease,
Aicardi–Goutieres
syndrome
(AGS)
are
linked
to
cancer.
Additionally,
functions
restriction
factor
for
retroviruses,
such
HIV.
Here,
we
review
current
biochemical
biological
properties
enzyme
including
its
structure,
activity,
regulation
post-translational
modifications
context
function.
We
outline
open
questions
regarding
biology
whose
answers
will
be
understanding
function
regulator
cell
cycle
progression,
genomic
integrity,
autoimmunity.
Experimental Hematology,
Journal Year:
2017,
Volume and Issue:
52, P. 32 - 39
Published: May 12, 2017
Sterile
alpha
motif
and
histidine/aspartic
acid
domain-containing
protein
1
(SAMHD1)
is
a
(deoxy)guanosine
triphosphate
(dGTP/GTP)-activated
deoxyribonucleoside
(dNTP)
triphosphohydrolase
involved
in
cellular
dNTP
homoeostasis.
Mutations
SAMHD1
have
been
associated
with
the
hyperinflammatory
disease
Aicardi-Goutières
syndrome
(AGS).
also
limits
cells'
permissiveness
to
infection
diverse
viruses,
including
human
immunodeficiency
virus
(HIV-1),
controls
endogenous
retroviruses.
Increasing
evidence
supports
role
of
as
tumor
suppressor.
However,
can
act
resistance
factor
nucleoside-based
chemotherapies
by
hydrolyzing
their
active
metabolites,
thereby
reducing
response
various
malignancies
these
anticancer
drugs.
Hence,
informed
cancer
therapies
must
take
into
account
ambiguous
properties
both
an
inhibitor
uncontrolled
proliferation
limiting
efficacy
treatments.
Here,
we
provide
that
double-edged
sword
for
patients
acute
myelogenous
leukemia
(AML).
Our
time-dependent
analyses
The
Cancer
Genome
Atlas
(TCGA)
AML
cohort
indicate
high
expression
SAMHD1,
even
though
it
critically
high-dose
ara-C
therapy,
might
be
more
favorable
progression.
Mobile DNA,
Journal Year:
2018,
Volume and Issue:
9(1)
Published: March 28, 2018
The
restriction
factor
SAMHD1
regulates
intracellular
nucleotide
level
by
degrading
dNTPs
and
blocks
the
replication
of
retroviruses
DNA
viruses
in
non-cycling
cells,
like
macrophages
or
dendritic
cells.
In
patients,
inactivating
mutations
samhd1
are
associated
with
autoimmune
disease
Aicardi-Goutières
Syndrome
(AGS).
accumulation
nucleic
acids
derived
from
endogenous
retroelements
thriving
absence
has
been
discussed
as
potential
trigger
reaction.
vitro,
found
to
restrict
retroelements,
LINE-1
elements
(L1).
mechanism,
however,
which
is
still
unclear.
Here,
we
show
that
inhibits
L1
other
cycling
By
applying
GFP-
neomycin-based
reporter
assays
anti-L1
activity
regulated
phosphorylation
at
threonine
592
(T592).
Similar
block
HIV,
cofactor
binding
site
enzymatic
active
HD
domain
proofed
be
essential
for
elements.
However,
T592
did
not
correlate
dNTP
hydrolase
293T
cells
suggesting
an
alternative
mechanism
regulation.
Interestingly,
binds
ORF2
protein
this
interaction
phosphorylation.
Together
finding
also
our
results
suggest
SAMHD1-mediated
inhibition
similar
but
identical
HIV
restriction.
Our
findings
conclusively
restricts
vitro.
important
maintaining
genome
integrity
support
idea
enhanced
vivo,
potentially
triggering
diseases
AGS.
analysis
contributes
better
understanding
activities
antiviral
defense
metabolism.
its
against
necessarily
suggests
might
only
function
controlling
autoimmunity.